Par Drugs And Chemicals Limited has informed the Exchange regarding Re-Appointment of M/s Sarupria Somani & Associates, Chartered Accountants as statutory auditor of the company w.e.f. April 01, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited held its 26th Annual General Meeting on September 27, 2025 in Vadodara, Gujarat, with 42 shareholders present out of 14,498 total shareholders. All 7 resolutions put to vote were approved with requisite majority. Key items passed include adoption of FY25 audited financial statements (99.99% in favor), re-appointment of Mr. Falgun Vallabhbhai Savani as Chairman & Managing Director via rotation (93.74% in favor), re-appointment of M/s Sarupria Somani & Associates as Statutory Auditors till the next AGM (99.85% in favor), appointment of M/s DG Patel & Associates as Secretarial Auditors for a 5-year term (FY 2025-26 to 2029-30), and re-appointment of Mrs. Bintal Bhaveshkumar Shah as Independent Director for a second 5-year term (September 28, 2025 to September 27, 2030). The resolutions on remuneration of an Independent Director and cost auditor ratification also passed comfortably.
This is a routine AGM outcome with all resolutions passing comfortably and no major red flags. The re-appointments ensure leadership and audit continuity for shareholders, and the 5-year terms for the secretarial auditor and independent director provide stability. Stock-price impact is likely neutral.